A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA(®)) and generic novo-methylphenidate ER-C (NOVO-generic)

Por Fallu, Angelo, Dabouz, Farida, Furtado, Melissa, Anand, Leena, Katzman, Martin A.
Publicado no Ther Adv Psychopharmacol (2016)

Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: Insights from the Canadian Trial of Atrial Fibrillation (CTAF)

Por Palardy, Maryse, Ducharme, Anique, Nattel, Stanley, Tardif, Jean-Claude, White, Michel, Racine, Normand, Tétreault, Karine, Dabouz, Farida, Talajic, Mario, Roy, Denis
Publicado em 2008